The study will evaluate the efficacy, immunogenicity and safety of the CoronaVac vaccine on children and adolescents aged 6 months to 17 years, the firms said in a statement.
The global trial will enroll 14,000 participants across Chile, the Philippines, Malaysia, Kenya including 2,000 in South Africa, they said. The trial has been approved by South African drugs regulator SAHPRA, and the first child will be vaccinated at the MeCRU Clinical Research Unit based at the Sefako Makgatho Health Sciences University on Friday.
"The primary objective of the study is to evaluate the efficacy of two doses of CoronaVac against confirmed symptomatic COVID-19 cases in children and adolescents ...efficacy will also be evaluated against hospitalisation and severe COVID-19," Sinovac and Numolux said.
If memory serves me right China's population is more than ours! Out of such large numbers of children they find them not suitable for their plans, so South Africa complies to every rubbish proposed to them. Let's go test on their children. . . We really doomed
Chinese jab 👀👀
sepedirock Every wrong thing is being done in SA
Why not in China, why here in South Africa we are doomed
Where does one sign up.
One of the ministers is a Chinese citizen to make sure we die softly washo no Roberta wathi killing me softly.
After they were rejected by Brazil👀
So they don't have childrens to do do trials by them We should seriously vote anc out no we can't go on like this.
🤔🙆🏿♂️
Ja ne 🙆♀️🙆♀️🙆♀️🙆♀️🙆♀️🙆♀️🙆♀️